|
Total Revenue
|
|
$310.3m
|
$295.4m
|
$227.8m
|
$228.7m
|
$223.0m
|
$331.9m
|
$337.6m
|
$226.5m
|
$284.9m
|
$390.7m
|
|
Cost of Revenue
|
|
$105.3m
|
$107.7m
|
$89.6m
|
$96.0m
|
$87.4m
|
$123.7m
|
$128.7m
|
$89.7m
|
$112.5m
|
$159.4m
|
|
Gross Profit
|
|
$205.0m
|
$187.7m
|
$138.1m
|
$132.7m
|
$135.6m
|
$208.1m
|
$208.9m
|
$136.8m
|
$172.3m
|
$231.3m
|
|
Operating Expenses
|
|
$144.7m
|
$163.3m
|
$178.6m
|
$182.4m
|
$196.7m
|
$237.8m
|
$283.2m
|
$291.4m
|
$298.9m
|
$313.8m
|
|
Operating Income (Loss)
|
|
$60.4m
|
$24.4m
|
($40.4m)
|
($49.6m)
|
($61.2m)
|
($29.6m)
|
($74.3m)
|
($154.6m)
|
($126.6m)
|
($82.5m)
|
|
Additional Financial Items
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of Intangible Assets
|
|
—
|
$3.0m
|
$4.7m
|
—
|
—
|
$7.8m
|
—
|
—
|
—
|
—
|
|
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$0
|
$0
|
|
Goodwill, Impairment Loss
|
|
$0
|
$0
|
$0
|
$0
|
$0
|
$0
|
$0
|
$0
|
$0
|
$0
|
|
Income (Loss) from Continuing Operations before Income Taxes, Domestic
|
|
$3.1m
|
$2.7m
|
$1.4m
|
$845k
|
$8k
|
($5.8m)
|
($19.0m)
|
($34.0m)
|
($35.6m)
|
($25.1m)
|
|
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic
|
|
$0
|
$0
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
|
|
$60.9m
|
$25.7m
|
($34.6m)
|
($41.6m)
|
($57.3m)
|
($28.6m)
|
($70.9m)
|
($148.5m)
|
($117.7m)
|
($73.7m)
|
|
Net Income (Loss) Attributable to Parent
|
|
$57.8m
|
$18.9m
|
($30.4m)
|
($44.8m)
|
($59.8m)
|
($26.4m)
|
($65.4m)
|
($169.4m)
|
($117.1m)
|
($75.9m)
|
|
Earnings Per Share, Basic
|
|
$1.77
|
$0.57
|
($0.93)
|
($1.35)
|
($1.72)
|
($0.72)
|
($1.70)
|
($4.25)
|
($2.84)
|
($1.78)
|
|
Earnings Per Share, Diluted
|
|
$1.68
|
$0.55
|
($0.93)
|
($1.35)
|
($1.72)
|
($0.72)
|
($1.70)
|
($4.25)
|
($2.84)
|
($1.78)
|
|
Weighted Average Number of Shares Outstanding, Basic
|
|
32.7m
|
33.2m
|
32.7m
|
33.1m
|
34.7m
|
36.6m
|
38.4m
|
39.9m
|
41.3m
|
42.7m
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
|
34.3m
|
34.6m
|
32.7m
|
33.1m
|
34.7m
|
36.6m
|
38.4m
|
39.9m
|
41.3m
|
42.7m
|
|
Research and Development Expense
|
|
$101.2m
|
$115.5m
|
$128.1m
|
$129.7m
|
$140.8m
|
$167.3m
|
$204.9m
|
$215.1m
|
$226.1m
|
$238.5m
|
|
Selling, General and Administrative Expense
|
|
$43.4m
|
$47.8m
|
$50.5m
|
$52.6m
|
$56.0m
|
$70.4m
|
$78.2m
|
$76.3m
|
$72.8m
|
$75.3m
|
|
Current Income Tax Expense (Benefit)
|
|
$2.1m
|
$4.8m
|
$2.9m
|
$3.0m
|
$3.0m
|
$2.7m
|
($955k)
|
$2.0m
|
($251k)
|
$2.3m
|
|
Equipment Expense
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$26.1m
|
$27.1m
|
|
Labor and Related Expense
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$115.2m
|
$131.0m
|
|
Operating Lease, Expense
|
|
—
|
—
|
—
|
$3.0m
|
$3.0m
|
$3.5m
|
$3.7m
|
$3.7m
|
$3.8m
|
$3.6m
|
|
Income Tax Expense (Benefit)
|
|
$3.1m
|
$6.9m
|
($4.1m)
|
$3.2m
|
$2.5m
|
($2.2m)
|
($5.6m)
|
$20.9m
|
($602k)
|
$2.2m
|